FIELD: medicine, ophthalmology. SUBSTANCE: eye drops have the main active component - 3,4-dihydro-2,8-diisopropyl-2-thioxo-2H-1,4-benzoxazine-4-ace- tic acid or its pharmaceutically acceptable salt and cyclodextrin. Drops can contain additionally water-soluble polymeric compound and chelating agent or boric acid taken at the definite weight ratios. This medicinal form does not cause eye irritation, its stable at storage. EFFECT: enhanced quality of eye drops. 7 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TOPICAL USE FOR TREATMENT OF EYE AND NOSE ALLERGIC DISEASES | 1993 |
|
RU2130774C1 |
METHOD OF STABILIZATION OF PRANOPROFEN (VARIANTS) AND PRANOPROFEN-BASE STABLE AQUEOUS PREPARATION | 1995 |
|
RU2148402C1 |
PHARMACEUTICAL COMPOSITION FOR GLAUCOMA TREATMENT | 1993 |
|
RU2102069C1 |
METHOD OF PREPARING AN AQUEOUS SUSPENSION AND AN AQUEOUS OPHTHALMIC PREPARATION | 1992 |
|
RU2098094C1 |
ANTIALLERGIC PHARMACEUTICAL COMPOSITION FOR LOCAL OCULAR APPLICATION AND METHOD FOR ITS PRODUCTION | 1994 |
|
RU2107497C1 |
ANTI-INFLAMMATORY OPHTHALMIC DROPS | 1995 |
|
RU2136252C1 |
SUBSTANCE FOR TREATMENT OF INFLAMMATORY OR ALLERGIC DISEASES | 1990 |
|
RU2050156C1 |
GLUTATHIONE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND A METHOD OF THEIR SYNTHESIS | 1991 |
|
RU2041201C1 |
GLUTATHIO ALKYL ESTERS OF OXIDIZING TYPE AND METHOD FOR THEIR PRODUCTION | 1991 |
|
RU2043994C1 |
LIQUID AQUEOUS OPHTHALMIC COMPOSITION | 2007 |
|
RU2445950C2 |
Authors
Dates
1996-10-27—Published
1991-08-12—Filed